HNGE

NEUTRALEarnings

HNGE

2026-07-13

Price

$90.00

+1.35%

This is the 2026-07-13 snapshot — the signals and analysis for HNGE as of this single trading day.

View full HNGE research hub →

Score4.5Watchlist

Signals4/8 DNA0/13 Act · 2/4 Risk

SentimentNEUTRALScore: 8

Volume1.4xvs 20d avg

Analysis

Hinge Health (HNGE) is exhibiting High-Conviction Price Discovery as it shrugs off massive insider selling to trade near all-time highs. Despite major shareholder Insight Holdings and other insiders offloading over $262 million in stock recently, institutional buyers are aggressively absorbing the supply, fueled by blowout Q1 earnings and 47% revenue growth. Supported by flawless technical signals (SURGE, ALPHA_MALE) and a RISK_ON macro regime that is entirely ignoring geopolitical headwinds, the stock's ability to digest this structural selling pressure confirms a powerful, institutionally backed breakout.

Fired Signals

SURGEALPHA MALEGOLDEN CROSSPERFECT STACKWEAK FINISHEXTENSION

Key Takeaways

Actionable Thesis: HNGE is a high-conviction long, demonstrating massive Institutional Absorption as it digests heavy insider supply without breaking its +45% monthly uptrend.
Key Risk: Sustained insider selling via 10b5-1 programs could eventually cap upside momentum if the broader RISK_ON regime shifts and institutional liquidity dries up.
What to Watch: Monitor the stock's ability to hold above the $64.75 line-in-the-sand support level heading into its upcoming Q2 earnings report.

← Back to 2026-07-13 View Full HNGE History →Yahoo Finance &nearr;